These findings suggest that inhibition of OCT2 is a promising approach against both CIN and CIO (Lanvers-Kaminsky et al., 2017; Gessner et al., 2019; McSweeney et al., 2021; Pasquariello et al., 2021). This evidence concerns the gene SLC22A2 and cervical squamous intraepithelial neoplasia.